BRIEF published on 10/02/2025 at 17:59, 2 months 2 days ago Kaufman & Broad Results for the First Nine Months of 2025 Financial Results Financial Structure Housing Market Outlook 2025 Commercial Performance
PRESS RELEASE published on 10/02/2025 at 17:54, 2 months 2 days ago Kaufman & Broad SA: RESULTS OF THE FIRST NINE MONTHS OF 2025 Kaufman & Broad SA reports positive results for the first nine months of 2025 with good commercial activity, strong financial structure, and maintained outlook. Revenue and net orders show significant growth Financial Structure Outlook Kaufman & Broad SA Results Commercial Activity
PRESS RELEASE published on 10/02/2025 at 17:54, 2 months 2 days ago Kaufman & Broad SA: RESULTS OF THE FIRST NINE MONTHS OF 2025 Kaufman & Broad SA announces results for the first nine months of 2025, showing good commercial activity and a strong financial structure. Outlook for the full year remains positive Financial Structure Outlook Kaufman & Broad SA Results Commercial Activity
BRIEF published on 07/25/2025 at 18:04, 4 months 10 days ago Kaufman & Broad indicted for Saint-Tropez concession Kaufman & Broad Judicial Investigation Indictment Saint-Tropez Development Concession
PRESS RELEASE published on 07/25/2025 at 17:59, 4 months 10 days ago Kaufman & Broad SA: Press release of the 2025, July 25 Kaufman & Broad SA contests allegations regarding a 2011 development concession in Saint-Tropez, Var, and is cooperating with judicial authorities Kaufman & Broad SA Allegations Saint-Tropez Development Concession Judicial Authorities
BRIEF published on 07/23/2025 at 17:51, 4 months 12 days ago Publication of Kaufman & Broad's 2025 Half-Year Financial Report AMF Financial Report Transparency Kaufman & Broad Half-yearly Accounts
PRESS RELEASE published on 07/23/2025 at 17:46, 4 months 12 days ago Kaufman & Broad SA: AVAILABILITY OF THE 2025 HALF YEARLY INTERIM FINANCIAL REPORT Kaufman & Broad SA announces availability of the 2025 Half Yearly Interim Financial Report on May 31, 2025, including consolidated financial statements and activity report Intérim Financial Report Kaufman & Broad 2025 Half Yearly
BRIEF published on 07/18/2025 at 17:51, 4 months 17 days ago Kaufman & Broad Initiates Share Buyback Program Share Buyback Investment Strategy Market Conditions Shareholders' Meeting Kaufman & Broad
PRESS RELEASE published on 07/18/2025 at 17:47, 4 months 17 days ago Kaufman & Broad SA: IMPLEMENTATION OF THE SHARE BUY-BACK PROGRAM Kaufman & Broad SA renews its share buy-back program, authorizing the buyback of up to 8.73% of shares. Details on company website Share Buy-back Program Shareholders' Meeting Kaufman & Broad Renewal Investment Services
PRESS RELEASE published on 07/18/2025 at 17:46, 4 months 17 days ago Kaufman & Broad SA: IMPLEMENTATION OF THE SHARE BUY-BACK PROGRAM Kaufman & Broad SA renews its irrevocable mandate to an investment services provider to buy back its shares, up to 8.73% of share capital, for 12 months based on market conditions Market Conditions Share Buy-back Program Kaufman & Broad SA Investment Services Provider Irrevocable Mandate
Published on 12/05/2025 at 02:35, 2 hours 49 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 24 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 19 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 24 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 53 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 33 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 58 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 8 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 13 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 24 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 39 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 39 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 23 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
